Astrocytes in culture can maintain glutamate uptake during hypoxia if glucose is available. To deter mine whether this capacity is shared by brain in situ, extracellular glutamate levels were measured in ischemic brain under conditions of continued glucose delivery. Mi crodialysis probes were placed bilaterally in caudate nu clei of rats and perfused with artificial cerebrospinal fluid (CSF) containing either 30 or 0 mM glucose. Global ce rebral ischemia was induced by cardiac arrest. Dialysate collected from probes not perfused with glucose showed a 50-fold increase in glutamate levels over the 60 min following cardiac arrest. Addition of glucose to the per-
The particular vulnerability of brain to ischemic injury is largely the result of extracellular accumu lation of excitatory amino acids (EAAs), chiefly glutamate, that are toxic to neurons (Choi, 1988) . Ischemic neuronal injury can be reduced by gluta mate receptor antagonists and by blockade of glu tamate release (Choi, 1988; Graham et al., 1993) . The role of glutamate uptake in reducing EAA neu rotoxicity during ischemia has received little study. Brain glutamate is taken up by energy-dependent mechanisms (Erecinska et al., 1986) , primarily into astrocytes (McLennan, 1976) . Under normal condi tions, the high capacity of brain glutamate uptake prevents the neuronal injury that might otherwise result from endogenous EAA release (Coyle et al., 1981) . Accordingly, neuronal injury does not usu ally occur even after the maximal neuronal depolar ization that follows spreading depression (Neder-1 fusate reduced the glutamate rise to <20% of the levels attained in the glucose-free probes. The glucose effect was negated by the addition of 0.5 mM of the glutamate uptake blocker threo-J3-hydroxyaspartate to the artificial CSF. These results show that oxygen is not required to maintain efficient uptake of extracellular glutamate in brain and suggest that elevations in extracellular gluta mate levels during ischemia result from metabolic pertur bations other than hypoxia. Key Words: Astrocyte Excitatory amino acid-Glutamate uptake-Ischemia Microdialysis-Threo-J3-hydroxy aspartate .
gaard and Hansen, 1988) or unsustained seizures (Brennan et aI., 1972; Meldrum et aI., 1973) . Failure of the uptake mechanisms may be necessary for acute EAA neurotoxicity in brain.
A TP depletion causes failure of EAA uptake and may also allow efflux of glutamate through the up take carriers (Nichols and Attwell, 1990; Ogata et al., 1992) . Astrocytes in culture can maintain ATP levels and continue glutamate uptake during hypox ia if glucose is still available (Swanson, 1992a) . This ability could potentially allow continued EAA up take in regions of incomplete ischemia, where oxy gen is depleted to a greater extent than glucose is depleted. In the present study, we sought to deter mine whether glutamate uptake in situ could be maintained under similar conditions. Anesthetized rats were subjected to cardiac arrest resulting in complete ischemia. Glucose was delivered to the region of a microdialysis catheter by perfusing the catheter with mock cerebrospinal fluid (CSF) con taining glucose, and glutamate levels in the recov ered dialysate were compared with those in a con tralaterally placed catheter perfused with glucose free solution. In a second experiment, the effect of catheter-delivered glucose on extracellular gluta mate accumulation was determined in the presence of the glutamate uptake inhibitor DL-threo-f3-hy droxyaspartate (TBHA).
METHODS
Male Sprague-Dawley rats (275-300 g) were fasted overnight to minimize variability in serum glucose levels. Anesthesia was induced with 5% isoflurane and main tained with 1.5% isoflurane after intubation. The femoral artery and vein were cannulated, and a temperature probe was placed in the temporalis muscle. Blood pressure and heart rate were monitored through the arterial line. The animals were placed in a Kopf stereotaxic frame and maintained at 37°C with a heat lamp. Four-millimeter mi crodialysis probes (Carnegie Medicin, Stockholm, Swe den) were inserted into the caudate nuclei bilaterally (an teroposterior bregma, 0.2; lateral, 4.0; depth, 6.0 mm). The probes were perfused at 4 fLlImin with mock CSF (Ames and Nesbitt, 1981) containing the following in mil limolars: NaCl, 119; KCI, 3.1; KH2P04, 0.5; NaHC03, 25; MgS04, 1.2; CaCl2, 1. 15. This solution was pH 7.2 and 300 mOsm (Wescor Vapor Pressure Osmometer, Lo gan, UT, U.S.A.) after equillibration with a 10% CO2/ 90% N2 atmosphere at 37°C. The mock CSF was supple mented with 30 mM glucose in one of the two catheters in each rat. Dialysate samples were collected at to-min in tervals beginning 60 min after placement of the catheters. After collection of two baseline samples, a 3-cc air bolus was injected through the femoral vein to cause cardiac arrest. These experiments were repeated in a second se ries of rats with the addition of 0.5 mM TBHA to the mock CSF-perfusing catheters with and without glucose. Sham-operated animals were prepared identically except without cardiac arrest.
Amino acids were measured by reverse-phase high performance liquid chromatography (HPLC) of the or thophthaldialdehyde derivatives using electrochemical detection as previously described (Graham et al., 1990) . The peak areas were by an observer who was blind to the experimental conditions using Nelson analytical soft ware.
Glucose delivery through the dialysis probes was de termined by measuring the difference in glucose concen trations in the perfusate before and after passage through the dialysis probe. This difference multiplied by the flow rate (4 fLlImin) yielded the amount of glucose delivered to brain. Glucose measurements were made with the spec trophotometric procedure of Lowry and Passonneau (1972) . Reagents were obtained from Sigma Chemical (St. Louis, MO, U.S.A.), unless otherwise noted.
RESULTS
Dialysates from probes perfused without glucose showed a prompt rise in extracellular glutamate af ter onset of ischemia (Fig. 1) . The glutamate levels began to plateau after 40 min of ischemia, reaching levels of approximately 50 times baseline values. Delivery of glucose through the probe reduced the rise in glutamate to eight times baseline at 40 min and 10 times baseline at 60 min. With the addition of 0.5 mM TBHA to the perfusates, the glutamate lev els from the glucose-perfused probes were not sig- nificantly different from levels in the glucose-free probes. Sham-treated rats showed little variation in glutamate recovery over the duration of the exper iments (Fig. 1) , and sham values for all amino acids were similar to baseline values of the ischemia group. The addition of 0.5 mM TBHA to the perfu sates appeared to increase glutamate concentra tions in dialysates from both ischemic and sham treated rats ( Fig. 1) , although different sets of ani mals and probes were used in these parallel experiments. Table 1 shows dialysate concentrations of other amino acids in samples taken at baseline and sam ples taken after 40 min of cerebral ischemia. At baseline (preischemia), perfusion of the dialysis probe with glucose had no significant effect on re covery of any of the amino acids analyzed. The addition of TBHA to the perfusate caused signifi cant elevations in baseline glutamate (p < 0.0 1) but not in other amino acids. Samples obtained after 40 min of ischemia showed that perfusion of the probes with glucose reduced dialysate levels of aspartate and -y-aminobutyric acid (GAB A) as well as gluta mate. The effects of glucose on these amino acid levels were negated by the addition of TBHA to the perfusing solutions. The amount of glucose delivered to brain through the probes was small and did not vary significantly between time points within treatment groups (not shown) or between treatment groups (Table 2) .
DISCUSSION
As previously reported, cerebral ischemia caused marked elevations in the extracellular concentra tions of glutamate and other amino acids (Bien veniste et aI., 1984; Drejer et aI., 1985; Globus et Glucose delivered to brain was calculated as [(nmol glucose/fLl entering probe) -(nmol glucose/fLl of dialysate)] x (4 fLI/min). Values are means ± SD from four or five rats in each group, with values for each animal averaged from collections at five time points; p > 0.3 for differences between groups by analysis of variance. aI., 1988; Graham et aI., 1990 Graham et aI., , 1993 . The local de livery of glucose through microdialysis probes re duced the rate and magnitUde of these elevations. Of the amino acids examined, this effect was re stricted to glutamate, aspartate, and GABA, each of which is taken up into neurons and glia by a high affinity active-transport mechanism (Erecinska et aI., 1986; Nichols and Attwell, 1990) . The glucose effect could result from increasing amino acid up take or, alternatively, decreasing amino acid re lease. Reduction in local release of amino acids would not, however, prevent diffusion of amino ac ids to the dialysis probe from surrounding ischemic brain and would consequently be unlikely to aff ect dialysate levels over the duration of these studies. Continued local uptake of amino acids could shield the probe from elevations in the surrounding tissue and cause the observed reduction in the dialysates.
To confirm that glucose acts by maintaining up take, these experiments were repeated in the pres ence of the competitive glutamate uptake inhibition TBHA. Both stereoisomers of this compound (Bal car et aI., 1977) are potent inhibitors of glutamate and aspartate uptake into neurons and glia (Rauen et aI., 1992; Taylor et al., 1992) . The failure of glu cose to reduce the ischemic rise of amino acid levels in the presence of the uptake blocker supports maintenance of uptake as the mechanism of action. This finding also excludes changes in osmolality or other physical interactions as causes of decreased glutamate recovery in the presence of glucose.
The peak dialysate glutamate levels were mark edly higher in the studies performed with TBHA. The cause of the increase is uncertain but may re flect heteroexchange of TBHA with intracellular glutamate (Taylor et aI., 1992) . TBHA also negated the effect of glucose on GAB A levels during isch emia, in addition to blocking the glucose effect on glutamate and aspartate levels (Fig. 1) . The effects of TBHA on GAB A uptake have not been reported, although other glutamate analogues can inhibit GABA uptake (Fyske et aI., 1992) . The TBHA ef fect on GAB A levels could also be indirect, as a result of increased neuronal exposure to glutamate.
The magnitude of the glucose effect is under scored by the very small amount of glucose deliv ered through the dialysis probes. Sokoloff and col leagues (1977) estimated the glucose utilization of anesthetized rat striatum to be 72 ± 3 nmol/100 mg/ min. Accordingly, at the measured glucose delivery rate of approximately 20 nmollmin, the probes could supply enough glucose for only 28 mg (-28 mm 3 ) of brain tissue in the presence of oxygen. Pre sumably, a much smaller volume could be fueled under the anaerobic conditions of ischemia, be cause in the absence of oxygen < 10% as much ATP can be generated from glucose. The reduction of glutamate levels at the probe required this small volume of tissue to remove glutamate of local origin as well as the far greater amount of glutamate dif fusing in from surrounding tissue.
The perfusate glucose concentration of 30 mM was chosen as a value likely to achieve significant local glucose delivery without causing a large in crease in osmolality. Although only a fraction of the perfusate glucose crossed the dialysis membrane, it is possible that tissue very close to the probe was exposed to supraphysiologic concentrations of glu cose. This possibility does not affect interpretation of the results, however, because glucolysis cannot be "driven" by high glucose concentrations. The hexokinase reaction is rate-limiting for glycolysis, and since brain hexokinase has a glucose Michaelis Menten constant (kM) of <0.1 mM (Thompson and Bachelard, 1977) , the brain is saturated at physio logic glucose concentrations.
EAAs are taken up into both neurons and glia, with glial uptake predominating (McLennan, 1976) . The present results are consistent with the ability of astrocytes in culture to maintain glutamate uptake during hypoxia (Swanson, 1992a) . The ability of as trocytes to function anaerobically may underlie the remarkably small amount of neuronal injury result ing from cyanide administration to animals when cardiac function is maintained (Brierly et aI., 1977; MacMillan, 1989) . Hypoxic neuronal injury is be- Vol. 14, No. I, 1994 lieved to result largely from release and accumula tion of EAAs (Choi, 1988) , and continued glucose delivery during hypoxia could prevent neuronal in jury by allowing continued astrocytic reuptake of EAAs. A growing body of evidence also suggests that, even under normal conditions, brain may re spond to increased energy demand by transiently increasing glycolysis out of proportion to oxidative metabolism (Fox et aI., 1988; Schasfoort et aI., 1988; Ackermann and Lear, 1989; Sappey-Marinier et aI., 1992; Swanson, 1992b) . The present results provide one example of an important brain function that can be fueled by glycolysis alone.
The tissue in close proximity to probes perfused with glucose was subjected to conditions similar to those affecting penumbral tissue during cerebral ar tery occlusion. Arterial occlusion may result in no blood flow to an ischemic core (complete ischemia) and reduced but nonzero blood flow (incomplete ischemia) in tissue at the margins of the ischemic core. Blood carries relatively more extractable glu cose than extractable oxygen (Mountcastle, 1980) , and areas of incomplete ischemia suffer oxygen de privation out of proportion to glucose deprivation and metabolize glucose to lactate by anaerobic gly colysis (Folbergova et aI., 1992) . One implication of the present study is that glycolytic metabolism could potentially fuel continued glutamate uptake and prevent excitotoxic neuronal injury during in complete ischemia in brain. Studies performed with 2-deoxyglucose autoradiography showed that focal ischemia does temporarily increase glycolytic flux in tissue with reduced but nonzero blood flow (Duffy et aI., 1980; Shiraishi et aI., 1989) . Although the present findings suggest that even a small deliv ery of glucose could substantially reduce EAA lev els in ischemic tissue, previous microdialysis stud ies have shown that glutamate uptake is not main tained during incomplete ischemia (Bienveniste et aI., 1984; Drejer et aI., 1985; Graham et aI., 1993) despite increased glycolytic metabolism. Therefore, either delivery of glucose is rate-limiting and insuf ficient or other, coexisting, metabolic perturbations prevent glutamate uptake despite glucose availabil ity.
Acidosis is one metabolic consequence of isch emia that may impair glutamate uptake. Studies in vitro show that astrocyte uptake fails under hypoxic conditions if pH falls to levels typically reached during cerebral ischemia (Swanson and Simon, 1993) . In the present study, the dialysis perfusion probably attenuated local acidosis, both by delivery of bicarbonate and by washout of lactic acid. In this aspect, the present model differs from incomplete ischemia with systemic hyperglycemia, in which in-creased delivery of glucose results in increased lac tic acidosis (Folbergova et aI., 1992) . Hyperglyce mia has been found to lessen ischemic injury in some models and worsen injury in others [see Gins berg et aI. (1987) , Nedergaard and Diemer (1987) and Yip et al. (1991) for review]. The results of the present study suggest that improved glucose deliv ery could potentially improve neuronal outcome from ischemia, but that other factors, particularly acidosis, can negate this effect. The variable results obtained in studies of ischemia with hyperglycemia may reflect varying contributions of these effects in different stroke models.
